Synthace gets $26 million funding from Horizons Ventures

London-based Synthace Ltd which is a cloud-based platform that helps improve the success rate of biological research, has secured a $25.6-million Series B funding round led by Hong Kong-based Horizons Ventures, the private investment arm of investor Li Ka-shing. Its existing investors, Luminous Ventures, SOSV and others also participated in the round.

Elvis Gomes